Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Sternberg

Showing results (291-300 of 564) with videos related to

Pageof 57
Sort By:
Cancer|September 15, 1993
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for infiltrating transitional cell carcinoma of the bladderC N Sternberg, M G Arena, F Calabresi, et al.
Future Oncology (London, England)|June 3, 2022
Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a patient and caregiver perspective and plain language summary of the ARASENS trialMatthew R Smith, Maha Hussain, Fred Saad, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 1994
Preparation and screening of an arrayed human genomic library generated with the P1 cloning systemN S Shepherd, B D Pfrogner, J N Coulby, et al.
The Lancet. Oncology|August 9, 2014
Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trialKarim Fizazi, Howard I Scher, Kurt Miller, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 3, 2009
In vitro inhibition of fungal activity by macrophage-mediated sequestration and release of encapsulated amphotericin B nanosupension in red blood cellsV Staedtke, M Brähler, A Müller, et al.
European Journal of Cancer (Oxford, England : 1990)|May 11, 2016
Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trialsGiandomenico Roviello, Sandra Sigala, Shahneen Sandhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2018
Pazopanib Exposure Relationship with Clinical Efficacy and Safety in the Adjuvant Treatment of Advanced Renal Cell CarcinomaCora N Sternberg, Frede Donskov, Naomi B Haas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Recombinant tumor necrosis factor for superficial bladder tumorsC N Sternberg, M G Arena, V Pansadoro, et al.
Oncology|April 30, 2014
Clinical presentation, pathological features and natural course of metastatic uveal melanoma, an orphan and commonly fatal diseaseLinda Cerbone, Rita Van Ginderdeuren, Joost Van den Oord, et al.
Cancer|August 15, 2013
Adjuvant leuprolide with or without docetaxel in patients with high-risk prostate cancer after radical prostatectomy (TAX-3501): important lessons for future trialsMichael T Schweizer, Peng Huang, Michael W Kattan, et al.
Pageof 57

Showing results (291-300 of 564) with videos related to

Sort By:
Pageof 57
Cancer|September 15, 1993
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for infiltrating transitional cell carcinoma of the bladderC N Sternberg, M G Arena, F Calabresi, et al.
Future Oncology (London, England)|June 3, 2022
Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a patient and caregiver perspective and plain language summary of the ARASENS trialMatthew R Smith, Maha Hussain, Fred Saad, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 1994
Preparation and screening of an arrayed human genomic library generated with the P1 cloning systemN S Shepherd, B D Pfrogner, J N Coulby, et al.
The Lancet. Oncology|August 9, 2014
Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trialKarim Fizazi, Howard I Scher, Kurt Miller, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 3, 2009
In vitro inhibition of fungal activity by macrophage-mediated sequestration and release of encapsulated amphotericin B nanosupension in red blood cellsV Staedtke, M Brähler, A Müller, et al.
European Journal of Cancer (Oxford, England : 1990)|May 11, 2016
Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trialsGiandomenico Roviello, Sandra Sigala, Shahneen Sandhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2018
Pazopanib Exposure Relationship with Clinical Efficacy and Safety in the Adjuvant Treatment of Advanced Renal Cell CarcinomaCora N Sternberg, Frede Donskov, Naomi B Haas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Recombinant tumor necrosis factor for superficial bladder tumorsC N Sternberg, M G Arena, V Pansadoro, et al.
Oncology|April 30, 2014
Clinical presentation, pathological features and natural course of metastatic uveal melanoma, an orphan and commonly fatal diseaseLinda Cerbone, Rita Van Ginderdeuren, Joost Van den Oord, et al.
Cancer|August 15, 2013
Adjuvant leuprolide with or without docetaxel in patients with high-risk prostate cancer after radical prostatectomy (TAX-3501): important lessons for future trialsMichael T Schweizer, Peng Huang, Michael W Kattan, et al.
Pageof 57